XCENA
Builds CXL computational memory chips and SDK for AI infrastructure in hyperscalers, telcos, and research
$135MSeries B
Role not disclosedKD
Korea Development Bank
Activity from announced rounds
Activity in this selectionUnited States
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $232M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionLatus Bio, Inc.
Engineers scalable AAV gene therapies for CNS and rare diseases including Huntington's disease and CLN2
$97MSeries A
Role not disclosed